Pharming
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Netherlands · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Vondellaan 47, Leiden, South Holland, 23...Phone Number
+31 715247400Website
www.pharming.comRevenue
$362.3 MillionStock Symbol
PHARMIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Pharming
Pharming Group N.V. is a global biopharmaceutical company focused on developing and commercializing innovative protein replacement therapies and precision medicines. Their mission is to serve the unserved rare disease patient community by addressing unmet medical needs. The company engages with various stakeholders including investors and partners to drive growth and innovation. They are committed to attracting talented individuals dedicated to improving the lives of patients.Explore more
Pharming Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pharming your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Pharming launches new products
Check if Pharming has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Pharming
Pharming, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Pharming recently announced quarterly report
Funding: Get notified immidiatlly once Pharming has new funding data
Click to see if Pharming had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Pharming is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Pharming as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Pharming is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pharming is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pharming.
Pharming financials insights
Gather financial insights about Pharming, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$17M
2017
Debt
$100M
Pharming Tech Stack
A closer look at the technologies used by Pharming
See more technologies
Most Recent Scoops
Open Position
Hiring Plans
Pharming has more open roles in Finance than it has had at any time in the past 12 months. Technologies mentioned include: Power BI, and Coupa. Areas of expertise include: Coordinate Systems, Corporate Governance, and Organizational Structure.
Hiring Plans
Open Position
Person-Based
Governance
Open Position
Pharming News & Media
Pharming Group (PHAR) Securities Investigation Notice - Levi & Korsinsky
Pharming Group told investors to expect up to $425 million in 2026 revenue. The Company now expects as little as $375 million -- and the stock lost 22% in a single session. NEW YORK, Aug. 7, 2026 /PRNewswire/ -- A 22% single-session decline hit Pharming Group (NASDAQ: PHAR) shareholders...Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
Pharming to participate in Canaccord Genuity 46th Annual Growth Conference in Boston on August 12-13, 2026.PHAR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Pharming Group
On May 7, 2026, Pharming Group's CEO reaffirmed full-year revenue guidance of $405 million to $425 million. Twelve weeks later, the Company cut that range to $375 million to $395 million and the stock fell 22%. NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Pharming Group (NASDAQ: PHAR)...Pharming Group Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Pharming Group (PHAR)
Pharming Group's legacy product RUCONEST posted a 10% year-over-year sales decline in Q2 2026 -- and PHAR shares fell 22% the day it was reported. Levi & Korsinsky is investigating potential securities law violations on behalf of PHAR shareholders. NEW YORK, July 31, 2026 /PRNewswire/ --...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Pharming
Sign Up For FreeTo access detailed company insights
Pharming Group N.V. is a global biopharmaceutical company focused on developing and commercializing innovative protein replacement therapies and precision medicines. Their mission is to serve the unserved rare disease patient community by addressing unmet medical needs. The company engages with various stakeholders including investors and partners... Read More
